Literature DB >> 35072780

Bone markers and bone mineral density associates with periodontitis in females with poly-cystic ovarian syndrome.

Afaf Zia1, S Hakim2, A U Khan3, A Bey4, H Ateeq5, S Parveen2, S Khalid3, Fnk Yusufi6.   

Abstract

INTRODUCTION: Studies suggest an association between poly-cystic ovarian syndrome (PCOS) and chronic periodontitis (CP), both being inflammatory conditions. However, insufficient evidence assesses the impact of this inflammation on bone metabolism and bone turnover markers (BTMs). The present study aimed to determine the association between BTMs, bone mineral density (BMD), and clinical periodontal parameters in PCOS women with CP.
MATERIALS AND METHODS: Three groups, each with 40 newly diagnosed (1) PCOS+CP, (2) PCOS alone, (3) CP alone, and fourth group (n = 20) systemically and periodontally healthy females aged 18-30 years were included in the study. Full mouth clinical periodontal parameters, C-terminal telopeptides of type I collagen (CTX), bone alkaline phosphatase (ALP), BMD and 25-hydroxyvitamin D (VD) were recorded for all.
RESULTS: Low BMD (0.89 ± 0.11 g/cm2), increased CTX levels (2.76 ± 4.64 ng/ml), decreased bone ALP levels (11.09 ± 6.86 ng/ml), higher VD levels (289.02 ± 168.28 nmol/l) and poor clinical periodontal status were observed in PCOS + CP females. BMD-spine showed weak positive correlation with CTX, bone ALP, VD (r = 0.02, r = 0.07, r = 0.15, respectively) in PCOS + CP group. ANCOVA depicted covariates had no confounding effect. Multiple regression model explained 21.0% for BMD-spine and 12.7% for BMD-femur of total variability signifying association with all measured parameters among all groups.
CONCLUSION: Enhanced inflammatory thrust by periodontitis increases CTX levels and decreases bone ALP and BMD levels in women with PCOS. Screening PCOS women for periodontal disease and vice versa may have a direct bearing on overall bone health.
© 2022. The Japanese Society Bone and Mineral Research.

Entities:  

Keywords:  Biomarkers; Bone biology; Endocrinology; Oral-systemic diseases; Periodontal diseases

Mesh:

Substances:

Year:  2022        PMID: 35072780     DOI: 10.1007/s00774-021-01302-6

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  32 in total

Review 1.  Clinical Review 116: Bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone.

Authors:  J V Zborowski; J A Cauley; E O Talbott; D S Guzick; S J Winters
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

Review 2.  Bone Density and Clinical Periodontal Attachment in Postmenopausal Women: A Systematic Review and Meta-Analysis.

Authors:  D C Penoni; T K S Fidalgo; S R Torres; V M Varela; D Masterson; A T T Leão; L C Maia
Journal:  J Dent Res       Date:  2017-01-03       Impact factor: 6.116

3.  The association between bone mineral density and periodontitis in Korean adults (KNHANES 2008-2010).

Authors:  J W Kim; K A Kong; H Y Kim; H S Lee; S J Kim; S H Lee; K W Sim; M R Kim; J H Lee
Journal:  Oral Dis       Date:  2013-10-01       Impact factor: 3.511

Review 4.  Association between periodontal disease and polycystic ovary syndrome: a systematic review.

Authors:  S V Kellesarian; V R Malignaggi; T V Kellesarian; A A Al-Kheraif; M M Alwageet; H Malmstrom; G E Romanos; F Javed
Journal:  Int J Impot Res       Date:  2017-03-09       Impact factor: 2.896

5.  Relationship of Bone Metabolism Biomarkers and Periodontal Disease: The Osteoporotic Fractures in Men (MrOS) Study.

Authors:  Ulrike Schulze-Späte; Ryan Turner; Ying Wang; Raylien Chao; P Christian Schulze; Kathy Phipps; Eric Orwoll; Thuy-Tien Dam
Journal:  J Clin Endocrinol Metab       Date:  2015-04-09       Impact factor: 5.958

6.  A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification.

Authors:  Jack G Caton; Gary Armitage; Tord Berglundh; Iain L C Chapple; Søren Jepsen; Kenneth S Kornman; Brian L Mealey; Panos N Papapanou; Mariano Sanz; Maurizio S Tonetti
Journal:  J Clin Periodontol       Date:  2018-06       Impact factor: 8.728

7.  Is interleukin-17 involved in the interaction between polycystic ovary syndrome and gingival inflammation?

Authors:  Özgün Özçaka; Nurcan Buduneli; Banu Ozturk Ceyhan; Aliye Akcali; Victoria Hannah; Christopher Nile; David F Lappin
Journal:  J Periodontol       Date:  2013-01-17       Impact factor: 6.993

8.  International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.

Authors:  Samuel Vasikaran; Cyrus Cooper; Richard Eastell; Andrea Griesmacher; Howard A Morris; Tommaso Trenti; John A Kanis
Journal:  Clin Chem Lab Med       Date:  2011-05-24       Impact factor: 3.694

9.  Diagnostic accuracy of salivary biomarkers of bone turnover in identifying patients with periodontitis in a Saudi Arabian population.

Authors:  Joseph Betsy; Javali Mukhatar Ahmed; Abdul Khader Mohasin; Amanullah Mohammed; AlQahtani Nabeeh A
Journal:  J Dent Sci       Date:  2019-03-29       Impact factor: 2.080

Review 10.  Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls.

Authors:  Selma Feldman Witchel; Sharon E Oberfield; Alexia S Peña
Journal:  J Endocr Soc       Date:  2019-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.